Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53a6c15bb56778040f9f654d0a2aa2b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e81afd7465ffba8139e557bd8c35b5eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
filingDate |
2018-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926ce4052fdc96f784137ab98e26745a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce89bcbb9e27708f0d7ecb9a7245586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee824095b89dac4158643e379a0e3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52f36ccb7c3c378b7cb2cab8020ba387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a13d97a306e9722dfe7c504225d4e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0eff9569c5f6b256b702174070632d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eb72aea5d3faaa3e6e12de25f24943d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51de4c52914eaf0a699088b9a7b61e6 |
publicationDate |
2020-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20200000615-A |
titleOfInvention |
Composition for Improving Atopy Dermatitis Using an Extract of Combretum quadrangulare |
abstract |
The present invention discloses a composition for improving atopic dermatitis using Combretum quadrangulale extract exhibiting MDC and TARC expression inhibitory activity when treated with HaCaT cells, human keratinocytes treated with INF-γ and TNF-α. . |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220076980-A |
priorityDate |
2018-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |